More on TENX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-110.5% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (3/25/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tenax Therapeutics (NQ:TENX)
Delayed: 10.69 -1.15 (9.71%)
Prev. Close $11.84  
Open$11.76 
52 Wk High$3.40 
52 Wk Low$1.34 
Day High$11.87 
Day Low$10.63 
P/E N/A  
EPS$0.00 
Volume209,050 

Friends, Peers and Foes (?): ABBV, AMGN, ANAB, BMY, CNTA (more...)

Mar 3, 2026 07:00 AM Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference
Feb 17, 2026 06:20 PM Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Venrock Healthcare Capital Partners III, L.P.
Feb 17, 2026 04:29 PM Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: BIOTECHNOLOGY VALUE FUND L P
Feb 17, 2026 04:28 PM Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Point72 Asset Management, L.P.
Feb 17, 2026 04:09 PM Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Lind Global Fund II LP
Feb 17, 2026 04:01 PM Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PERCEPTIVE ADVISORS LLC
Feb 17, 2026 09:56 AM Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Dellora Investments LP
Feb 17, 2026 08:52 AM Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: RTW INVESTMENTS, LP
Feb 12, 2026 01:21 PM Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: MORGAN STANLEY
Feb 4, 2026 07:00 AM Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026
View All Articles

Entities mentioned with TENX

View All Entities